You are using an outdated browser. Please upgrade your browser to improve your experience.
neuronal ceroid lipofuscinosis 9
Disease Summary
Associated Targets ()
Mondo Description Neuronal ceroid lipofuscinosis 9 (CLN9-NCL) is a rare condition that affects the nervous system. Signs and symptoms of the condition generally develop in early childhood (average age 4 years) and may include loss of muscle coordination (ataxia), seizures that do not respond to medications, muscle twitches (myoclonus), visual impairment, and developmental regression (the loss of previously acquired skills). The underlying genetic cause of CLN9-NCLis unknown but it appears to be inherited in an autosomal recessive manner. Treatment options are limited to therapies that can help relieve some of the symptoms.
Download Data for neuronal ceroid lipofuscinosis 9
data still loading...
Counts of Target Development Levels for diseases known to be associated with this disease. If the disease has a valid DOID, targets known to be associated with all child diseases are aggregated. Click "Explore Associated Targets" to view more facets and details for the target list.
Description from Mondo Disease Ontology.
DataSources which have contributed target associations to this disease, and the identifiers by which the disease is referenced.
DOID:0110733
GARD:0006618
MESH:C537953
OMIM:609055
Orphanet:228357
MONDO:0012188
High level summary of knowledge for a disease, including descriptions and datasource references. Click the "?" for more details.